|
Bictegravir (GS-9883), a Novel HIV-1 Integrase Strand Transfer Inhibitor (INSTI) with Optimized In Vitro Resistance Profile
|
|
|
Reported by Jules Levin
ASM Microbe, June 16-20, 2016, Boston, MA
Gregg Jones, Joshua Goldsmith, Andrew Mulato, Kirsten White, Derek Hansen, Kirsten Stray, Stephen Yant, Scott Lazerwith, Haolun Jin, Tomas Cihlar, Manuel Tsiang
Gilead Sciences, Foster City, CA
|
|
|
|
|
|
|